Quick-Med Technologies Company Description
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies.
It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products.
The company’s core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials.
In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products.
Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
| Country | United States |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Bernd Liesenfeld |
Contact Details
Address: 902 NW 4th Street Gainesville, Florida 32601 United States | |
| Phone | 352-379-0611 |
| Website | quickmedtech.com |
Stock Details
| Ticker Symbol | QMDT |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US74837Q1067 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gregory S. Schultz Ph.D. | Chairman and Scientific Advisor |
| Dr. Bernd Liesenfeld Ph.D. | Principal Executive Officer, President and Director |